rs7874043

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000506891.1(TTC39B):​c.*299T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0413 in 152,860 control chromosomes in the GnomAD database, including 159 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.041 ( 159 hom., cov: 32)
Exomes 𝑓: 0.017 ( 0 hom. )

Consequence

TTC39B
ENST00000506891.1 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.890

Publications

6 publications found
Variant links:
Genes affected
TTC39B (HGNC:23704): (tetratricopeptide repeat domain 39B) Predicted to be involved in several processes, including cholesterol homeostasis; negative regulation of cholesterol storage; and regulation of cholesterol efflux. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000506891.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 9-15249433-A-C is Benign according to our data. Variant chr9-15249433-A-C is described in ClinVar as Benign. ClinVar VariationId is 1225250.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0624 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000506891.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTC39B
NM_152574.3
MANE Select
c.77+18481T>G
intron
N/ANP_689787.3A0A8V8PNE1
TTC39B
NM_001168339.2
c.77+18481T>G
intron
N/ANP_001161811.2
TTC39B
NM_001168340.2
c.77+18481T>G
intron
N/ANP_001161812.2A0A8V8NCV2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TTC39B
ENST00000506891.1
TSL:1
c.*299T>G
3_prime_UTR
Exon 4 of 4ENSP00000427314.2H0YAJ6
TTC39B
ENST00000512701.7
TSL:2 MANE Select
c.77+18481T>G
intron
N/AENSP00000422496.2A0A8V8PNE1
TTC39B
ENST00000505732.5
TSL:1
n.312+18481T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0413
AC:
6290
AN:
152152
Hom.:
160
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0644
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0416
Gnomad ASJ
AF:
0.0176
Gnomad EAS
AF:
0.0624
Gnomad SAS
AF:
0.0462
Gnomad FIN
AF:
0.0524
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0435
GnomAD4 exome
AF:
0.0170
AC:
10
AN:
588
Hom.:
0
Cov.:
0
AF XY:
0.0102
AC XY:
4
AN XY:
392
show subpopulations
African (AFR)
AF:
0.0833
AC:
1
AN:
12
American (AMR)
AF:
0.100
AC:
2
AN:
20
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8
South Asian (SAS)
AF:
0.00
AC:
0
AN:
16
European-Finnish (FIN)
AF:
0.0714
AC:
1
AN:
14
Middle Eastern (MID)
AF:
0.250
AC:
1
AN:
4
European-Non Finnish (NFE)
AF:
0.0102
AC:
5
AN:
488
Other (OTH)
AF:
0.00
AC:
0
AN:
24
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0414
AC:
6302
AN:
152272
Hom.:
159
Cov.:
32
AF XY:
0.0434
AC XY:
3232
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0645
AC:
2679
AN:
41544
American (AMR)
AF:
0.0416
AC:
636
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0176
AC:
61
AN:
3470
East Asian (EAS)
AF:
0.0621
AC:
322
AN:
5184
South Asian (SAS)
AF:
0.0469
AC:
226
AN:
4822
European-Finnish (FIN)
AF:
0.0524
AC:
556
AN:
10602
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0254
AC:
1725
AN:
68032
Other (OTH)
AF:
0.0426
AC:
90
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
306
613
919
1226
1532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0317
Hom.:
56
Bravo
AF:
0.0406
Asia WGS
AF:
0.0510
AC:
178
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
11
DANN
Benign
0.88
PhyloP100
0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7874043;
hg19: chr9-15249431;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.